Enantiomer ratio of MK-0767 in humans and nonclinical species

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 9, 2005, Pages 1125-1129

  Shen, Zhongzhou ^a   Bakhtiar, Ray ^a   Komuro, Masakatsu ^b   Awano, Katsuya ^b   Taga, Fukutaro ^b   Colletti, Adria ^a   Hora, Don ^a   Feeney, William ^a   Iliff, Susan ^a   Franklin, Ronald B ^a   Vincent, Stella ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT; PROTEINS; RATS;

BENZAMIDES; IN-VITRO; IN-VIVO; METHOXY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; S RATIO; THIAZOLIDINEDIONES; TRIFLUOROMETHYL; TYPE-2 DIABETES; VITRO AND IN VIVO;

ENANTIOMERS;

EID: 18544385515     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.1897     Document Type: Article

References (23)

1. Murakami K, Tobe K, Ide T, Mochizuki T, Ohashi M, Akanuma Y, Yazaki Y, Kadowaki T. Diabetes 1998; 47: 1841.
2. Medicinal Chemistry 12th RSC-SCI Symposium (Part III), Norman PIDdb Meeting Report, Cambridge, UK, 2003
3. Parks DJ, Tomkinson NC, Villeneuve MS, Blanchard SG, Willson TM. Bioorg. Med. Chem. Lett. 1998; 15: 3657.
4. Cantello BC, Cawthorne MA, Cottam GP, Duff PT, Haigh D, Hindley RM, Lister GA, Smith SA, Thurlby SL. J. Med. Chem. 1994; 37: 3977.
5. Nomura M, Kinoshita S, Satoh H, Maeda T, Murakami K, Tsunoda M, Miyachi H, Awano K. Bioorg. Med. Chem. Lett. 1999; 9: 533.
6. Chilocot J, Tappenden P, Jones ML, Wight JP. Clin. Ther. 2001; 23: 1792.
7. Welch CJ, Kress MH, Beconi M, Mathre DJ. Chirality 2003; 15: 143.
8. Sahoo SP, Santini C, Boueres JK, Heck JV, Metzger E, Lombardo VK. PCT Int. Appl.2000; WO0078312.
9. Sohda T, Mizuno K, Kawamatsu Y. Chem. Pharm. Butt. 1984; 32: 4460.
10. Gaupp S, Effenberger F. Tetrahedron: Asymmetry 1999; 10: 1777.
11. Doebber T, Kelly LJ, Zhou G, Meurer R, Biswas C, Li Y, Wu MS, Ippolito MC, Chao Y, Wang P, Wright SD, Moller DE, Berger JP. Biochem. Biophys. Res. Commun. 2004; 318: 323.
12. Caldwell J. J. Chromatogr. 1996; 719: 3.
13. Center for Proprietary and Medicinal Products. Directive 75/318/EEC as amended, investigation of chiral active substances., June, 1994
14. Yan K, Song H, Lo M. J. Chromatogr. B 2004; 813: 95.
15. Aso Y, Yoshioka S, Takeda Y. Chem. Pharm. Bull. 1990; 38: 180.
16. Severin G. Chirality 1992; 4: 222.
17. Fernandez C, Gimenez F, Thuillier A, Farinotti R. Chirality 1999; 11: 329.
18. Twine SM, Gore MG, Morton P, Fish BC, Lee AG, East JM. Arch. Biochem. Biophys. 2003; 414: 83.
19. Tsuda Y, Tsunoi T, Watanabe N, Ishida M, Yamada H, Itoh T. Chirality 2001; 13: 236.
20. Bharatam P, Khanna S. J. Phys. Chem. 2004; 108: 3784.
21. Kassahun K, Pearson PG, Tang W, McIntosh I, Leung K, Elmore C, Dean D, Wang R, Doss G, Baillie TA. Chem. Res. Toxicol. 2001; 14: 62.
22. Karanam BV, Hop CECA, Liu DQ, Wallace M, Dean D, Vincent SH. Drug Metab. Dispos. 2004; 32: 1015.
23. Liu DQ, Karanam BV, Doss G, Sidler R, Vincent SH, Hop CECA. Drug Metab. Dispos. 2004; 32: 1023.